Top 10 Companies in the Romania ADHD Medication Market | Insights & Key Players 2026

Q: Which global players lead the stimulant medication segment in the Romania ADHD medication market?

Janssen and Takeda are leading the stimulant segment, through the distribution of OROS-methylphenidate and lisdexamfetamine, which are widely used for symptom management.

Q: Are any domestic players producing innovative or affordable treatments for ADHD in Romania?

Regional manufacturers like Zentiva Romania and Antibiotice Iași are quite active in providing affordable generic formulations and essential CNS treatments for the domestic demographic.

Q: What underlying factors are driving the growth of the Romania ADHD medication market?

The market is primarily driven by increased clinical awareness among healthcare professionals, the integration of European treatment guidelines, and a significant rise in adult ADHD diagnoses.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA12396

Publication Date: May 2026

Top 10 Companies in the Romania ADHD Medication Market

The Romania ADHD Medication Market is experiencing rapid growth, due to the longstanding presence of global pharmaceutical giants and the increased involvement of European regional players. Major players in the market include Eli Lilly, Janssen (Johnson & Johnson), Takeda, and Angelini Pharma.

Romania ADHD Medication Market Overview

According to 6Wresearch, the Romania ADHD Medication Market is poised for significant expansion, driven by an evolving healthcare landscape and an increasing prevalence of neurodevelopmental diagnoses. The increased occurrence of adult ADHD and improved paediatric screening are strengthening the demand for a diverse range of pharmacological interventions. Also, improved healthcare infrastructure, along with consumer awareness about brain health and mental well-being, is further boosting the innovation of advanced therapies, which includes long-acting stimulants and non-stimulant alternatives.

Competitive Landscape

The competitive landscape of the Romania ADHD medication industry is defined by continuous investment in regulatory compliance and strategic distribution partnerships across the European Union. The market is highly competitive as key players strive to offer a comprehensive portfolio that spans from essential stimulants to advanced non-stimulant formulations for complex cases.

Below is a list of leading players operating in the Romania ADHD Medication Market:

1. Eli Lilly and Company

Company Name	Eli Lilly and Company
Established Year	1876 (Global) / 2011 (Lilly Romania)
Headquarters	Indianapolis, USA (Global) / Bucharest, Romania
Official Website	Click Here

Eli Lilly is a pivotal player in the Romanian market, primarily known for Strattera, a leading non-stimulant treatment for ADHD.

2. Janssen (Johnson & Johnson Romania)

Company Name	Janssen (Johnson & Johnson Romania)
Established Year	1953 (Global) / 1993 (Romania)
Headquarters	Beerse, Belgium (Global) / Bucharest, Romania
Official Website	Click Here

Janssen is a dominant leader in the ADHD space, providing Concerta, which utilizes OROS technology for controlled release in adult patients.

3. Takeda Romania

Company Name	Takeda Romania
Established Year	1781 (Global) / 2011 (Local Entity)
Headquarters	Tokyo, Japan (Global) / Bucharest, Romania
Official Website	Click Here

Takeda maintains a strong presence with its specialized CNS portfolio, focusing on the introduction and distribution of long-acting treatments.

4. Angelini Pharma Romania

Company Name	Angelini Pharma Romania
Established Year	1919 (Global) / 2011 (Romania)
Headquarters	Rome, Italy (Global) / Bucharest, Romania
Official Website	Click Here

Angelini Pharma is a key regional contributor, specializing in Brain Health and offering a range of therapeutic solutions for neurological disorders.

5. Novartis Romania

Company Name	Novartis Romania
Established Year	1996 (Merger)
Headquarters	Basel, Switzerland (Global) / Bucharest, Romania
Official Website	Click Here

Novartis contributes to the market through its legacy in CNS treatments and its Sandoz division, which provides high-quality generic methylphenidate options.

6. Zentiva Romania

Company Name	Zentiva Romania
Established Year	1488 (Legacy) / 1962 (Sicomed Romania)
Headquarters	Prague, Czech Republic (Global) / Bucharest, Romania
Official Website	Click Here

Zentiva is a local manufacturing powerhouse known for its robust portfolio of CNS generic medications and affordable therapeutic alternatives.

7. Antibiotice Iași

Company Name	Antibiotice Iași
Established Year	1955
Headquarters	Iași, Romania
Official Website	Click Here

Antibiotice Iași provides essential CNS drugs and is increasingly focused on expanding its portfolio to address mental health disorders.

8. Sandoz Romania

Company Name	Sandoz Romania
Established Year	2003 (Sandoz Brand)
Headquarters	Holzkirchen, Germany (Global) / Târgu Mureș, Romania
Official Website	Click Here

Sandoz is a leader in off-patent ADHD medications, offering various methylphenidate formulations that provide cost-effective options for the healthcare system.